Page 160 - Let them speak Towards a patient reported outcome measure set for

Chapter 6
References
Agar, G., C. Brown, D. Sutherland, S. Coulborn, C. Oliver, and C. Richards. 2021. Sleep disorders
in rare genetic syndromes: a meta-analysis of prevalence and profile. Molecular Autism, 12,
1–17.
American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders:
DSM-5, American Psychiatric Association.
Arron, K., C. Oliver, J. Moss, K. Berg, and C. Burbidge. 2011. The prevalence and phenomenology of
self‐injurious and aggressive behaviour in genetic syndromes. Journal of Intellectual Disability
Research, 55, 109–120.
Basch, E., P. Torda, and K. Adams. 2013. Standards for patient-reported outcome–based
performance measures. JAMA, 310, 139–140.
Boot, E., N. J. Butcher, T. A. van Amelsvoort, et al. 2015. Movement disorders and other motor
abnormalities in adults with 22q11. 2 deletion syndrome. American Journal of Medical
Genetics Part A, 167, 639–645.
Borland, R., N. Hu, B. Tonge, S. Einfeld, and K. Grey. 2020. Participation in sport and physical activity
in adults with intellectual disabilities. Journal of Intellectual Disability Research, 64, 908–922.
Castrén, E., Y. Elgersma, L. Maffei, and R. Hagerman. 2012. Treatment of neurodevelopmental
disorders in adulthood. Journal of Neuroscience, 32, 14074–14079.
Cella, D., S. Yount, N. Rothrock, et al. 2007. The Patient-Reported Outcomes Measurement
Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first
two years. Medical Care, 45, S3–s11.
Clarke, M. 2007. Standardising outcomes for clinical trials and systematic reviews. Trials, 8, 1–3.
Crossnohere, N. L., A. L. Schuster, J. Bruckel, et al. 2025. Patient-reported outcome measures add
value as clinical trial endpoints. Nature Medicine, 1–4.
Dawalt, L. S., L. V. Usher, J. S. Greenberg, and M. R. Mailick. 2019. Friendships and social participation
as markers of quality of life of adolescents and adults with fragile X syndrome and autism.
Autism, 23, 383–393.
Dawson, F., S. Shanahan, E. Fitzsimons, G. O’Malley, N. Mac Giollabhui,and J. Bramham. 2016. The
impact of caring for an adult with intellectual disability and psychiatric comorbidity on carer
stress and psychological distress. Journal of Intellectual Disability Research, 60, 553–563.
De Knegt, N. C., F. Lobbezoo, C. Schuengel, H. M. Evenhuis, and E.J. Scherder. 2017. Self-reported
presence and experience of pain in adults with Down syndrome. Pain Medicine, 18, 1247–
1263.
Djukic, A., R. Holtzer, S. Shinnar, et al. 2016. Pharmacologic treatment of Rett syndrome with
glatiramer acetate. Pediatric Neurology, 61, 51–57.
Elefante, E., C. Tani, C. Stagnaro, et al. 2020. Impact of fatigue on health-related quality of life and
illness perception in a monocentric cohort of patients with systemic lupus erythematosus.
RMD open, 6, e001133.
EMA 2022. Patient experience data in medicines development and regulatory decision-making.
https://www.ema.europa.eu/en/events/multi-stakeholder-workshop-patient-experience-data-
medicines-development-regulatory-decision-making#documents-section.
ERICA. 2023. PROMs Repository [Online]. Available: https://erica-rd.eu/work-packages/patient-
centred-research/proms-repository/ [Accessed].
FDA 2006. Guidance for industry: patient-reported outcome measures: use in medical product
development to support labeling claims: draft guidance. Health and Quality of Life Outcomes,
4, 1–20.
FDA 2024. FDA Patient-Focused Drug Development Guidance Series for Enhancing the Incorporation
of the Patient’s Voice in Medical Product Development and Regulatory Decision Making.
https://www.fda.gov/drugs/development-approval-process-drugs/fda-patient-focused-drug-
development-guidance-series-enhancing-incorporation-patients-voice-medical.
Feldman, M., J. Bosett, C. Collet, and P. Burnham-Riosa. 2014. Where are persons with intellectual
disabilities in medical research? A survey of published clinical trials. Journal of Intellectual
Disability Research, 58, 800–809.
158